Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

47437

Sigma-Aldrich

Fmoc-D-Tic-OH

≥98.0% (TLC)

Synonym(s):

(R)-N-Fmoc-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C25H21NO4
CAS Number:
130309-33-0
Molecular Weight:
399.44
Beilstein:
7499344
MDL number:
MFCD00144345
UNSPSC Code:
12352200
PubChem Substance ID:
57650954

Assay

≥98.0% (TLC)

optical activity

[α]20/D −25.0±2°, c = 0.6% in methanol

application(s)

peptide synthesis

functional group

Fmoc

storage temp.

2-8°C

SMILES string

OC(=O)[C@H]1Cc2ccccc2CN1C(=O)OCC3c4ccccc4-c5ccccc35

InChI

1S/C25H21NO4/c27-24(28)23-13-16-7-1-2-8-17(16)14-26(23)25(29)30-15-22-20-11-5-3-9-18(20)19-10-4-6-12-21(19)22/h1-12,22-23H,13-15H2,(H,27,28)/t23-/m1/s1

InChI key

LIRBCUNCXDZOOU-HSZRJFAPSA-N

Other Notes

FMOC-D-Tic is employed e.g. for the solid-phase synthesis of Bradykinin antagonists

Storage Class Code

13 - Non Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
413083/1

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

C Thurieau et al.
Journal of medicinal chemistry, 39(10), 2095-2101 (1996-05-10)
We report here on the synthesis and pharmacological properties of a new series of small linear and cyclic peptides derived from the five C-terminal amino acid residues of second-generation bradykinin receptor antagonists. Variations of the two first residues of the
V S Goodfellow et al.
Journal of medicinal chemistry, 39(7), 1472-1484 (1996-03-29)
We report a systematic probing of the structural requirements of the bradykinin (BK) type 2 (B(2)) receptor for antagonist activity by incorporating N-alkyl-amino acid residues at positions 7 and 8 of a potent antagonist sequence. Compound 1 (D-Arg(0)-Arg(1)-Pro(2)-Hyp(3)-Gly(4)-Thi(5)-Ser(6)-D-Tic(7)-N-Chg (8)-Arg(9), CP-0597)(1,2)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service